Table 4.
Antibiotic susceptibility testing in multidrug-resistant organisms.
| Antibiotics | Organisms | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Enterococcus faecium | Klebsiella pneumoniae | Acinetobacter baumannii | Stenotrophomonas maltophilia | |||||||
| No. of isolates | 1 | 1 | 2 | 3 | 4 | 1 | 2 | 1 | 2 | 3 |
| Penicillin | R | |||||||||
| Ampicillin | R | R | R | R | R | |||||
| Amoxicillin-CLA | S | |||||||||
| Ampicillin-SUL | R | |||||||||
| Piperacillin | R | R | S | R | R | R | ||||
| Piperacillin-TZP | S | S | R | |||||||
| Vancomycin | R | |||||||||
| Teicoplanin | R | |||||||||
| Linezolid | S | |||||||||
| Tigecycline | S | S | R | R | I | |||||
| Gentamicin | R | R | R | R | R | R | ||||
| High level GM | R | |||||||||
| Amikacin | R | R | R | S | R | R | S | S | S | |
| Cefazolin | R | R | R | R | R | |||||
| Cefuroxime | R | R | R | R | R | R | R | R | ||
| Ceftriaxone | R | R | R | R | R | R | ||||
| Ceftazidime | R | R | R | R | R | R | R | R | R | |
| Floxomef | R | R | S | S | R | |||||
| Cefepime | R | |||||||||
| Aztreonam | R | R | R | R | R | |||||
| TMP-SMX | R | R | R | R | R | R | R | |||
| Ciprofloxacin | S | R | S | S | R | R | ||||
| Levofloxacin | R | R | R | |||||||
| Moxifloxacin | R | R | R | |||||||
| Imipenem | S | S | S | |||||||
| Meropenem | S | R | ||||||||
| Ertapenem | S | |||||||||
| Colistin | S | |||||||||
CLA clavulanic acid, I intermediate, S susceptible, SUL sulbactam, R resistant, TMP-SXT trimethoprim-sulfamethoxazole, TZP tazobactam.